Controversial Use of Antibiotics in Patient with Sars-Cov-2
Main Article Content
Abstract
Background: The SARS-CoV-2 coronavirus is a new type of coronavirus that can affect people and the disease it causes is called COVID-19. Coronaviruses are enveloped RNA viruses that cause respiratory illnesses of varying severity, from the common cold to deadly pneumonia. The WHO first learned of the existence of this new virus on December 31, 2019, when it was informed of a group of cases of "viral pneumonia" that had been declared in Wuhan.
Methodology: A narrative review was carried out through various databases from January 2020 to June 2021; the search and selection of articles was carried out in journals indexed in English. The following keywords were used: Coronavirus, Sars-Cov 2, Covid 19, ARDS in Covid 19, Antibiotics Associated with Sars-Cov 2
Results: There are no controlled clinical trials evaluating the use of empirical antimicrobials in patients with COVID-19 or other coronaviruses. Therefore, the recommendations are based on extrapolation of data from other viral pneumonias that may suffer from bacterial superinfection, particularly viral pneumonias due to influenza.
Conclusions: The present review seeks to clarify the functional role that antimicrobials have with respect to infection by sars-cov 2 (COVID-19), in which circumstances they are necessary to use them and which do not merit it.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Wei, W., Ortwine, J. K., Mang, N. S., Joseph, C., Hall, B. C., & Prokesch, B. C. (2020). Limited role for antibiotics in COVID-19: scarce evidence of bacterial coinfection. Available at SSRN 3622388.
II. Lucien, M. A. B., Canarie, M. F., Kilgore, P. E., Jean-Denis, G., Fénélon, N., Pierre, M., & Ramon-Pardo, P. (2021). Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. International Journal of Infectious Diseases, 104, 250-254.
III. Chedid, M., Waked, R., Haddad, E., Chetata, N., Saliba, G., & Choucair, J. (2021). Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy. Journal of infection and public health, 14(5), 570.
IV. Miranda, C., Silva, V., Capita, R., Alonso-Calleja, C., Igrejas, G., & Poeta, P. (2020). Implications of antibiotics use during the COVID-19 pandemic: present and future. Journal of Antimicrobial Chemotherapy, 75(12), 3413-3416.
V. Liu, C., Wen, Y., Wan, W., Lei, J., & Jiang, X. (2021). Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19. International immunopharmacology, 90, 107157.
VI. Sulis, G., Batomen, B., Kotwani, A., Pai, M., & Gandra, S. (2021). Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis. PLoS medicine, 18(7), e1003682.
VII. Gagliotti, C., Buttazzi, R., Ricchizzi, E., Di Mario, S., Tedeschi, S., & Moro, M. L. (2021). Community use of antibiotics during the COVID-19 lockdown. Infectious Diseases, 53(2), 142-144.
VIII. Leis, J. A., Born, K. B., Theriault, G., Ostrow, O., Grill, A., & Johnston, K. B. (2020). Using antibiotics wisely for respiratory tract infection in the era of covid-19. bmj, 371.
IX. Yacouba, A., Olowo-Okere, A., & Yunusa, I. (2021). Repurposing of antibiotics for clinical management of COVID-19: a narrative review. Annals of Clinical Microbiology and Antimicrobials, 20(1), 1-8.
X. Abu-Rub, L. I., Abdelrahman, H. A., Johar, A. R. A., Alhussain, H. A., Hadi, H. A., & Eltai, N. O. (2021). Antibiotics Prescribing in Intensive Care Settings during the COVID-19 Era: A Systematic Review. Antibiotics, 10(8), 935.
XI. Comber, S. D., Upton, M., Lewin, S., Powell, N., & Hutchinson, T. H. (2020). COVID-19, antibiotics and One Health: a UK environmental risk assessment. Journal of Antimicrobial Chemotherapy, 75(11), 3411-3412.
XII. Alzoubi, H., Alnawaiseh, N., Al-Mnayyis, A., Abu-Lubad, M., Aqel, A., & Al-Shagahin, H. (2020). COVID-19-knowledge, attitude and practice among medical and non-medical University Students in Jordan. J Pure Appl Microbiol, 14(1), 17 24.
XIII. Hantoushzadeh, S., & Norooznezhad, A. H. (2020). Possible cause of inflammatory storm and septic shock in patients diagnosed with (COVID-19). Archives of medical research, 51(4), 347-348.
XIV. Movahed, S. M. M., Akhavizadegan, H., Dolatkhani, F., Nejadghaderi, S. A., Aghajani, F., Gangi, M. F., ... & Ghasemi, H. (2021). Different incidences of acute kidney injury (AKI) and outcomes in COVID‐19 patients with and without non‐azithromycin antibiotics: A retrospective study. Journal of medical virology, 93(7), 4411.